trial · primary record
MST-168
Neoplams
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 420 |
| Primary completion | 2030-06-30 |
| Primary endpoint | Incidence of dose-limiting toxicities (DLT) |
| Registry ID | NCT07644650 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:40:19.905Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07644650
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.